| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.58▼ | 1.58▼ | 1.58▼ | 1.58▼ | 1.48▲ |
| MA10 | 1.59▼ | 1.59▼ | 1.59▼ | 1.50▲ | 1.66▼ |
| MA20 | 1.60▼ | 1.58▼ | 1.50▲ | 1.45▲ | 6.53▼ |
| MA50 | 1.47▲ | 1.44▲ | 1.43▲ | 1.75▼ | 43.87▼ |
| MA100 | 1.44▲ | 1.53▲ | 1.60▼ | 7.87▼ | 115.58▼ |
| MA200 | 1.62▼ | 1.76▼ | 1.93▼ | 37.42▼ | 474.73▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.016▼ | -0.012▼ | 0.001▲ | 0.080▲ | 2.575▲ |
| RSI | 51.982▲ | 53.263▲ | 55.430▲ | 43.735▼ | 24.376▼ |
| STOCH | 40.995 | 35.043 | 42.223 | 68.421 | 16.259▼ |
| WILL %R | -66.667 | -66.667 | -54.545 | -40.373 | -94.349▼ |
| CCI | -75.969 | -78.222 | -14.931 | 60.451 | -59.358 |
|
Monday, April 28, 2025 08:02 AM
EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting ...
|
|
Monday, April 28, 2025 06:00 AM
(RTTNews) - Evaxion Biotech A/S (EVAX) announced new data underscoring ... of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan ...
|
|
Monday, April 28, 2025 05:13 AM
The ongoing phase 2 trial with EVX-01 remains on track for two-year data readout in the second half of 2025 COPENHAGEN, Denmark, April 28, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 1.54 | 1.57 | 1.54 | 1.56 | 12,384 |
| 30/04/25 | 1.44 | 1.56 | 1.4209 | 1.53 | 40,446 |
| 29/04/25 | 1.63 | 1.63 | 1.51 | 1.51 | 48,592 |
| 28/04/25 | 1.67 | 1.7699 | 1.5501 | 1.65 | 208,021 |
| 25/04/25 | 1.59 | 1.70 | 1.59 | 1.65 | 59,797 |
| 24/04/25 | 1.57 | 1.6687 | 1.4625 | 1.59 | 90,643 |
| 23/04/25 | 1.42 | 1.60 | 1.36 | 1.49 | 162,506 |
| 22/04/25 | 1.31 | 1.3999 | 1.28 | 1.37 | 75,991 |
| 21/04/25 | 1.28 | 1.32 | 1.25 | 1.305 | 36,833 |
| 17/04/25 | 1.31 | 1.315 | 1.25 | 1.309 | 62,979 |
|
|
||||
|
|
||||
|
|